The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa
Open accessAbstract
A standard panel of subtype C human immunodeficiency virus type 1 (HIV-1) Env-pseudotyped viruses was created by cloning, sequencing, and characterizing functional gp160 genes from 18 acute and early heterosexually acquired infections in South Africa and Zambia. In general, the gp120 region of these clones was shorter (most evident in V1 and V4) and less glycosylated compared to newly transmitted subtype B viruses, and it was underglycosylated but no different in length compared to chronic subtype C viruses. The gp120s also exhibited low amino acid sequence variability (12%) in V3 and high variability (39%) immediately downstream of V3, a feature shared with newly transmitted subtype B viruses and chronic viruses of both subtypes. When tested as Env-pseudotyped viruses in a luciferase reporter gene assay, all clones possessed an R5 phenotype and resembled primary isolates in their sensitivity to neutralization by HIV-1-positive plasmas. Results obtained with a multisubtype plasma panel suggested partial subtype preference in the neutralizing antibody response to infection. The clones were typical of subtype C in that all were resistant to 2G12 (associated with loss of N-glycosylation at position 295) and most were resistant to 2F5, but all were sensitive to 4E10 and many were sensitive to immunoglobulin G1b12. Finally, conserved neutralization epitopes in the CD4-induced coreceptor binding domain of gp120 were poorly accessible and were difficult to induce and stabilize with soluble CD4 on Env-pseudotyped viruses. These results illustrate key genetic and antigenic properties of subtype C HIV-1 that might impact the design and testing of candidate vaccines. A subset of these gp160 clones are suitable for use as reference reagents to facilitate standardized assessments of vaccine-elicited neutralizing antibody responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
(1987) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040454 · Cited by 59,715
CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP
Felsenstein, J. (1985) · Evolution · doi:10.1111/j.1558-5646.1985.tb00420.x · Cited by 44,647
Kimura, M. (1980) · Journal of Molecular Evolution · doi:10.1007/bf01731581 · Cited by 29,778
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationThe HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569 · cited 2×
“Cells. TZM-bl (JC53-bl) cells were obtained from the NIH ARRRP as contributed by John Kappes and Xiaoyun Wu. This is a genetically engineered HeLa cell clone that expresses CD4, CXCR4, and CCR5 and contains Tat-responsive reporter genes for firefly luciferase (Luc) and Escherichia coli -galactosidase under regulatory…”
MethodSelf-citationChange in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
Fast and sensitive multiple sequence alignments on a microcomputer
Higgins, D. G., & Sharp, P. M. (1989) · Bioinformatics · doi:10.1093/bioinformatics/5.2.151 · Cited by 1,218
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationCD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Self-citationA conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Self-citationA new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
Self-citationA Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Diversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Self-citationZwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., & Putney, S. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6768 · Cited by 618
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Self-citationEvaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Self-citationKuiken, C., Foley, B., Freed, E., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., & Korber, B. (2002) · doi:10.2172/1184349 · Cited by 570
Self-citationGain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus
Bubić, I., Wagner, M., Krmpotić, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjić, S., & Koszinowski, U. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7536-7544.2004 · Cited by 569
A role for carbohydrates in immune evasion in AIDS
Reitter, J. N., Means, R. E., & Desrosiers, R. C. (1998) · Nature Medicine · doi:10.1038/nm0698-679 · Cited by 558
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Sexual behavior of HIV discordant couples after HIV counseling and testing
Allen, S., Meinzen-Derr, J., Kautzman, M., Zulu, I., Trask, S., Fideli, U., Musonda, R., Kasolo, F., Gao, F., & Haworth, A. (2003) · AIDS · doi:10.1097/00002030-200303280-00012 · Cited by 496
Self-citationCocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., & Lusso, P. (1996) · Nature Medicine · doi:10.1038/nm1196-1244 · Cited by 495
van't Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A., Albrecht-van Lent, N., Scherpbier, H. J., Veenstra, J., Boer, K., Coutinho, R. A., Miedema, F., & Schuitemaker, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117560 · Cited by 493
Zhang, L. Q., MacKenzie, P., Cleland, A., Holmes, E. C., Brown, A. J., & Simmonds, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3345-3356.1993 · Cited by 468
Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Self-citationRobbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
PURTSCHER, M., TRKOLA, A., GRUBER, G., BUCHACHER, A., PREDL, R., STEINDL, F., TAUER, C., BERGER, R., BARRETT, N., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1651 · Cited by 347
Moore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042510 · Cited by 295
Self-citationHIV-1 genomic rna diversification following sexual and parenteral virus transmission
Wolfs, T. F. W., Zwart, G., Bakker, M., & Goudsmit, J. (1992) · Virology · doi:10.1016/0042-6822(92)90685-i · Cited by 293
Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4694-4703.1998 · Cited by 292
Self-citationSpeck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B., & Goldsmith, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7136-7139.1997 · Cited by 275
Understanding the genetic diversity of HIV-1.
McCutchan, F. E. (2000) · PubMed · Cited by 270
Pantophlet, R., Saphire, E. O., Poignard, P., Parren, P. W. H. I., Wilson, I. A., & Burton, D. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.642-658.2003 · Cited by 244
Moore, J. P., Cao, Y., Leu, J., Qin, L., Korber, B., & Ho, D. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.427-444.1996 · Cited by 221
Self-citationCao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt, R., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9808-9812.1997 · Cited by 219
Self-citationMontefiori, D. C., Robinson, W. E., Schuffman, S. S., & Mitchell, W. M. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.2.231-235.1988 · Cited by 201
Self-citationCilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A., & Morris, L. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4449-4456.2003 · Cited by 201
Self-citationPing, L.-H., Nelson, J. A. E., Hoffman, I. F., Schock, J., Lamers, S. L., Goodman, M., Vernazza, P., Kazembe, P., Maida, M., Zimba, D., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6271-6281.1999 · Cited by 196
Frost, S. D. W., Liu, Y., Pond, S. L. K., Chappey, C., Wrin, T., Petropoulos, C. J., Little, S. J., & Richman, D. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6523-6527.2005 · Cited by 185
Back, N. K. T., Smit, L., De Jong, J.-J., Keulen, W., Schutten, M., Goudsmit, J., & Tersmette, M. (1994) · Virology · doi:10.1006/viro.1994.1141 · Cited by 182
Prospects for Vaccine Protection Against HIV-1 Infection and AIDS
Letvin, N. L., Barouch, D. H., & Montefiori, D. C. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.094854 · Cited by 179
Self-citationIncreased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants
Kolchinsky, P., Kiprilov, E., & Sodroski, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2041-2050.2001 · Cited by 171
Precious, H. M., Günthard, H. F., Wong, J. K., D'Aquila, R. T., Johnson, V. A., Kuritzkes, D. R., Richman, D. D., & Brown, A. J. L. (2000) · AIDS · doi:10.1097/00002030-200001070-00004 · Cited by 163
Rizzuto, C. D., & Sodroski, J. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200308747 · Cited by 159
Kostrikis, L. G., Cao, Y., Ngai, H., Moore, J. P., & Ho, D. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.445-458.1996 · Cited by 158
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
Self-citationBures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., Habib, R. E., Klein, M. C. A., Lazzarin, A., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054756 · Cited by 147
Self-citationCecilia, D., Kulkarni, S., Tripathy, S. P., Gangakhedkar, R., Paranjape, R., & Gadkari, D. A. (2000) · Virology · doi:10.1006/viro.2000.0297 · Cited by 143
Barbato, G., Bianchi, E., Ingallinella, P., Hurni, W. H., Miller, M. D., Ciliberto, G., Cortese, R., Bazzo, R., Shiver, J. W., & Pessi, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00611-9 · Cited by 136
Salzwedel, K., Smith, E. D., Dey, B., & Berger, E. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.326-333.2000 · Cited by 132
Brown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J. D., Sanders‐Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E., & Polonis, V. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6089-6101.2005 · Cited by 128
Self-citationCharacterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
Williamson, C. E., Morris, L., Maughan, M. F., Ping, L., Dryga, S. A., Thomas, R. K., Reap, E. A., Cilliers, T., Harmelen, J. H. V., Pascual, Á., et al. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203762688649 · Cited by 125
Self-citationMultiple aligned sequence editor (MASE)
Faulkner, D. V., & Jurka, J. (1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90129-6 · Cited by 119
Damme, L. V., Chandeying, V., Gita Ramjee, H., Rees, H., Sirivongrangson, P., Laga, M., & Perriëns, J. (2000) · AIDS · doi:10.1097/00002030-200001070-00010 · Cited by 98
Xiang, S.-H., Wang, L., Abreu, M., Huang, C.-C., Kwong, P. D., Rosenberg, E. S., Robinson, J. E., & Sodroski, J. (2003) · Virology · doi:10.1016/s0042-6822(03)00521-x · Cited by 82
Self-citationGray, E. S., Meyers, T., Gray, G., Montefiori, D. C., & Morris, L. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030255 · Cited by 82
Self-citationZhang, P. F., Bouma, P., Park, E. J., Margolick, J. B., Robinson, J. E., Zolla‐Pazner, S., Flora, M. N., & Quinnan, G. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.644-655.2002 · Cited by 79
Self-citationThe Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan
Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020025 · Cited by 72
Lee, W. R., Yu, X. F., Syu, W. J., Essex, M., & Lee, T. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1799-1803.1992 · Cited by 50
Urgently needed: a filter for the HIV-1 vaccine pipeline
Moore, J. P., & Burton, D. R. (2004) · Nature Medicine · doi:10.1038/nm0804-769 · Cited by 39
Cited by
Salazar-Gonzalez, J. F., Salazar, M. G., Keele, B. F., Learn, G. H., Giorgi, E. E., Li, H., Decker, J. M., Wang, S., Baalwa, J., Kraus, M. H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090378 · Cited by 764
Self-citationSeaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Self-citationMeasuring HIV Neutralization in a Luciferase Reporter Gene Assay
Montefiori, D. C. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-170-3_26 · Cited by 583
Self-citationHIV-1 neutralizing antibodies induced by native-like envelope trimers
Sanders, R. W., van Gils, M. J., Derking, R., Sok, D., Ketas, T. J., Burger, J. A., Ozorowski, G., Cupo, A., Simonich, C., Goo, L., et al. (2015) · Science · doi:10.1126/science.aac4223 · Cited by 496
Self-citationHIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Metadata
- Authors
- Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., Mlisana, K., Karim, S. A., Hong, K., Greene, K. M., Bilska, M., Zhou, J., Allen, S., Chomba, E., Mulenga, J., Vwalika, C., Gao, F., Zhang, M., Korber, B. T. M., Hunter, E., Hahn, B. H., & Montefiori, D. C.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-12
- Volume
- 80
- Issue
- 23
- Pages
- 11776-11790
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2110499527
- Cited by
- 359
- References
- 77
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.